http://www.huliq.com/tags/sutent The taxonomy view with a depth of 0. en http://www.huliq.com/16114/sutent-achieves-first-line-eau-approval-for-kidney-cancer <strong>Sutent (sunitinib malate) </strong>has received a European Association of Urology (EAU) recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma (mRCC). http://www.huliq.com/16114/sutent-achieves-first-line-eau-approval-for-kidney-cancer#comments Health kidney cancer progression-free survival renal cell carcinoma sunitinib malate Sutent Thu, 22 Mar 2007 12:47:55 -0500 harminka 16114 at http://www.huliq.com